AFFX Affymetrix, Inc.

InterMune Inc. (ITMN) was a big mover last session, as the company saw its shares rise over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company since Dec 19.    

The company has seen no estimate revision over the past 30 days and the Zacks Consensus Estimate has not been in a trend either. Yesterday’s price jump is encouraging though, so make sure to keep a close watch on this firm in the near future.

InterMune currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, better-ranked stocks in the medicine-biomedicine gene industry include Affymetrix Inc. (AFFX), Genomic Health Inc. (GHDX) and Neuralstem, Inc. (CUR). While Affymetrix and Gentium sport a Zacks Rank #1 (Strong Buy), Neuralstem has a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
 
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
 
GENOMIC HEALTH (GHDX): Free Stock Analysis Report
 
INTERMUNE INC (ITMN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research